Pharma Archives - Boston Life Sciences Times

MassBio Rare Disease Day Forum to Spotlight Research Progress and Patient Challenges

February 20, 2026

Vizgen to Unveil Spatial Multi-Omics Roadmap at AGBT 2026

February 19, 2026

Insulet Posts Strong Q4, Full-Year 2025 Growth as Omnipod Demand Accelerates

February 18, 2026

THIS WEEK'S STORIES

FDA Approves Calquence–Venetoclax Combination as First All-Oral Fixed-Duration Option for Newly Diagnosed CLL

February 20, 2026

Ibex Medical Analytics Names New CEO, Expands Push Into Biopharma as Global Adoption Grows

February 18, 2026

Turn Therapeutics Names Dr. Robert Redfield Senior Advisor for Health Policy and Regulatory Affairs

February 17, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Tag: Pharma

Most Read

MassBio Rare Disease Day Forum to Spotlight Research Progress and Patient Challenges

OPTAVIA Metabolic Health Program Becomes Eligible for HSA and FSA Reimbursement

Meta-Analysis Links Trial Assessment Frequency to Placebo Response in Anxiety Studies

FDA Approves Calquence–Venetoclax Combination as First All-Oral Fixed-Duration Option for Newly Diagnosed CLL

EDITOR PICKS

MassBio Rare Disease Day Forum to Spotlight Research Progress and Patient Challenges

Vizgen to Unveil Spatial Multi-Omics Roadmap at AGBT 2026

Insulet Posts Strong Q4, Full-Year 2025 Growth as Omnipod Demand Accelerates

THIS WEEK'S STORIES

FDA Approves Calquence–Venetoclax Combination as First All-Oral Fixed-Duration Option for Newly Diagnosed CLL

Ibex Medical Analytics Names New CEO, Expands Push Into Biopharma as Global Adoption Grows

Turn Therapeutics Names Dr. Robert Redfield Senior Advisor for Health Policy and Regulatory Affairs

POPULAR CATEGORY

ABOUT US

FOLLOW US